Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001648213-16-000003
Filing Date
2016-03-24
Accepted
2016-03-24 15:06:47
Documents
1
Effectiveness Date
2016-03-24
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 7918
  Complete submission text file 0001648213-16-000003.txt   8941
Mailing Address 60 HAZELWOOD DRIVE CHAMPAIGN IL 61820
Business Address 60 HAZELWOOD DRIVE CHAMPAIGN IL 61820 217-377-8866
Aptimmune Biologics, Inc. (Filer) CIK: 0001648213 (see all company filings)

EIN.: 272467088 | State of Incorp.: IL | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-243862 | Film No.: 161526796